Features Screener Stocks Charts
Sign In Sign Up

Wockhardt Ltd. Income Statement

NSE:WOCKPHARMA | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year WOCKPHARMA income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 28.81B 30.74B
Cost of Revenue -11.65B -12.38B
Gross Profit 17.16B 18.36B
Sales, General & Admin -15.94B -14.87B
Operating Income -1.01B 1.32B
Profit Before Tax -4.20B -160.00M
Net Income -4.72B -570.00M
Diluted Shares 144.47M 155.63M
Diluted EPS -32.05 -3.02

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025